comparemela.com

Latest Breaking News On - Hematologic oncology - Page 1 : comparemela.com

Dr Carraway on the Importance of NGS in Relapsed/Refractory AML

Hetty E. Carraway, MD, MBA, discusses the importance of testing for targetable mutations in patients with relapsed/refractory acute myeloid leukemia.

Division-of-hematologic-oncology
Oncology-program
Enterprise-development
Department-of-medicine
Case-comprehensive-cancer-center
Taussig-cancer-institute
School-of-medicine
Cleveland-clinic-lerner-college
Case-western-reserve-university
Immune-oncology-program
Hematologic-oncology

Physician Advocate: Healing During the AIDS Epidemic

Physician Advocate: Healing During the AIDS Epidemic
dartmouth.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dartmouth.edu Daily Mail and Mail on Sunday newspapers.

Columbia-university
New-york
United-states
San-francisco
California
Daniel-lucey
Jeffrey-fennelly
Division-of-hematologic-oncology
National-cancer-institute
Member-of-the-program-in-molecular-pharmacology
Columbia-university-school-of-social-work
Women-research-initiative

Dr Koehne on the Use of Chemotherapy-Only Conditioning Regimens in Hematologic Malignancies

Dr Koehne on the Use of Chemotherapy-Only Conditioning Regimens in Hematologic Malignancies
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Miami
Florida
United-states
Guenther-koehne
Miami-cancer-institute
Baptist-health
Marrow-transplant
Hematologic-oncology
Benign-hematology

Uproleselan Plus Chemotherapy Misses Phase 3 Trial OS End Point in R/R AML

Uproleselan plus chemotherapy did not achieve a statistically significant improvement in OS vs chemotherapy alone in patients with relapsed/refractory AML.

China
United-states
Chinese
Harout-semerjian
Chinese-national-medical-products-administration
National-cancer-institute
Alliance-for-clinical-trials-in-oncology
Clinical-trials
Hematologic-oncology
News
Acute-myeloid-leukemia
Uprolesan

AML, ALL, and Glioblastoma Multiforme Clinical Trials Seek to Push the Needle Forward

Leland Metheny, MD, discusses how agents such as Iomab-B have potential to shift practice in the hematologic malignancy space.

Cleveland
Ohio
United-states
Leland-metheny
Oncology-program-at-case-comprehensive-cancer-center
University-hospitals-cleveland-medical-center
Case-western-reserve-university-school-of-medicine
Case-western-reserve-university-school
Immune-oncology-program
Case-comprehensive-cancer-center
Hematologic-oncology
D

vimarsana © 2020. All Rights Reserved.